Evidence map›Paper›PMID 33919401›Full record

ReviewNanomaterials (Basel, Switzerland)2021

Gold Nanoparticles Synthesis and Antimicrobial Effect on Fibrous Materials.

Behnaz Mehravani, Ana Isabel Ribeiro, Andrea Zille

Open access · goldAbstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Behnaz Mehravani2C2T-Centro de Ciência e Tecnologia Têxtil, Campus de Azúrem, Universidade do Minho, 4800-058 Guimaraes, Portugal.ORCID 0000-0002-9635-2902
Ana Isabel Ribeiro2C2T-Centro de Ciência e Tecnologia Têxtil, Campus de Azúrem, Universidade do Minho, 4800-058 Guimaraes, Portugal.ORCID 0000-0001-9556-6311
Andrea Zille2C2T-Centro de Ciência e Tecnologia Têxtil, Campus de Azúrem, Universidade do Minho, 4800-058 Guimaraes, Portugal.ORCID 0000-0001-5299-4164
University of Minho · PT

Funding

FCT - Fundação para a Ciência e a Tecnologia PTDC/CTM-TEX/28295/2017FCT - Fundação para a Ciência e a Tecnologia SFRH/BD/137668/2018FCT - Fundação para a Ciência e a Tecnologia UID/CTM/00264/2019
6 · The paper itself

Abstract

Depositing nanoparticles in textiles have been a promising strategy to achieve multifunctional materials. Particularly, antimicrobial properties are highly valuable due to the emergence of new pathogens and the spread of existing ones. Several methods have been used to functionalize textile materials with gold nanoparticles (AuNPs). Therefore, this review highlighted the most used methods for AuNPs preparation and the current studies on the topic in order to obtain AuNPs with suitable properties for antimicrobial applications and minimize the environmental concerns in their production. Reporting the detailed information on the functionalization of fabrics, yarns, and fibers with AuNPs by different methods to improve the antimicrobial properties was the central objective. The studies combining AuNPs and textile materials have opened valuable opportunities to develop antimicrobial materials for health and hygiene products, as infection control and barrier material, with improved properties. Future studies are needed to amplify the antimicrobial effect of AuNPs onto textiles and minimize the concerns related to the synthesis.

Indexed as

antibacterial propertiesfunctionalizationgold nanoparticlesin situtextiles

Identifiers

PMID33919401
PMCPMC8143294
OpenAlexW3156277546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.